Cite Filings / DNLI / 0001714899-19-000032
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

Denali Therapeutics Inc. · Filed 2019-05-08 · Acc 0001714899-19-000032

Documents 1

  • 10-Q Quarterly Report , dnli-20190331.htm

Around this filing

  • 2019-08-06 10-Q Quarterly Report
  • 2019-05-10 4 Chief Medical Officer sold 17,500 shares at an average $22.85 ($399,901)
  • 2019-05-10 4/A Chief Medical Officer sold 36,912 shares at an average $25.44 ($938,976)
  • 2019-05-08 10-Q Quarterly Report
  • 2019-05-08 8-K Results of operations
  • 2019-05-03 4 President and CEO sold 18,334 shares at an average $24.20 ($443,744)
  • 2018-11-08 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading dnli-20190331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…